JBIO
Price
$11.14
Change
+$0.34 (+3.15%)
Updated
Jul 3 closing price
Capitalization
359.11M
36 days until earnings call
KLRS
Price
$2.50
Change
-$0.06 (-2.34%)
Updated
Jul 3 closing price
Capitalization
46.76M
Interact to see
Advertisement

JBIO vs KLRS

Header iconJBIO vs KLRS Comparison
Open Charts JBIO vs KLRSBanner chart's image
Jade Biosciences
Price$11.14
Change+$0.34 (+3.15%)
Volume$110.75K
Capitalization359.11M
Kalaris Therapeutics
Price$2.50
Change-$0.06 (-2.34%)
Volume$35.7K
Capitalization46.76M
JBIO vs KLRS Comparison Chart in %
Loading...
JBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KLRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JBIO vs. KLRS commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBIO is a Hold and KLRS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (JBIO: $11.14 vs. KLRS: $2.50)
Brand notoriety: JBIO and KLRS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JBIO: 25% vs. KLRS: 75%
Market capitalization -- JBIO: $359.11M vs. KLRS: $46.76M
JBIO [@Biotechnology] is valued at $359.11M. KLRS’s [@Biotechnology] market capitalization is $46.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JBIO’s FA Score shows that 1 FA rating(s) are green whileKLRS’s FA Score has 1 green FA rating(s).

  • JBIO’s FA Score: 1 green, 4 red.
  • KLRS’s FA Score: 1 green, 4 red.
According to our system of comparison, both JBIO and KLRS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JBIO’s TA Score shows that 3 TA indicator(s) are bullish while KLRS’s TA Score has 4 bullish TA indicator(s).

  • JBIO’s TA Score: 3 bullish, 5 bearish.
  • KLRS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KLRS is a better buy in the short-term than JBIO.

Price Growth

JBIO (@Biotechnology) experienced а +20.43% price change this week, while KLRS (@Biotechnology) price change was -2.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

JBIO is expected to report earnings on Aug 11, 2025.

KLRS is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JBIO($359M) has a higher market cap than KLRS($46.8M). KLRS YTD gains are higher at: 495.238 vs. JBIO (320.377).
JBIOKLRSJBIO / KLRS
Capitalization359M46.8M767%
EBITDAN/AN/A-
Gain YTD320.377495.23865%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/A101M-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
JBIOKLRS
RSI
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
69%
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
JBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KLRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FINV9.840.33
+3.47%
FinVolution Group
CBIO15.890.35
+2.22%
Crescent Biopharma Inc
ATNM1.440.01
+0.70%
Actinium Pharmaceuticals
HD371.68-0.17
-0.05%
Home Depot
LEGN35.64-0.27
-0.75%
Legend Biotech Corp

JBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBIO has been closely correlated with OVID. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if JBIO jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBIO
1D Price
Change %
JBIO100%
+3.15%
OVID - JBIO
79%
Closely correlated
+2.39%
KNSA - JBIO
35%
Loosely correlated
+1.60%
SYRE - JBIO
30%
Poorly correlated
+1.68%
KPRX - JBIO
29%
Poorly correlated
-0.35%
VANI - JBIO
26%
Poorly correlated
N/A
More

KLRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KLRS has been loosely correlated with PTHS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if KLRS jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLRS
1D Price
Change %
KLRS100%
-2.34%
PTHS - KLRS
44%
Loosely correlated
-1.91%
SPRO - KLRS
21%
Poorly correlated
+0.34%
VRTX - KLRS
9%
Poorly correlated
+0.57%
JBIO - KLRS
6%
Poorly correlated
+3.15%
ANRO - KLRS
5%
Poorly correlated
+2.17%
More